Quantitative [Fe]MRI of PSMA-targeted SPIONs specifically discriminates among prostate tumor cell types based on their PSMA expression levels

References

• ShinTHChoiYKimSCheonJRecent advances in magnetic nanoparticle-based multi-modal imagingChem Soc Rev201544144501451625652670
   PubMed Web of Science ®Google Scholar
• TaylorRMSillerudLOPaclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent mannerInt J Nanomedicine201274341435222915856
   PubMed Web of Science ®Google Scholar
• LoYLChouHLLiaoZXChondroitin sulfate-polyethylenimine copolymer-coated superparamagnetic iron oxide nanoparticles as an efficient magneto-gene carrier for microRNA-encoding plasmid DNA deliveryNanoscale20157188554856525897645
   PubMed Web of Science ®Google Scholar
• WangCDingCKongMTumor-targeting magnetic lipoplex delivery of short hairpin RNA suppresses IGF-1R overexpression of lung adenocarcinoma A549 cells in vitro and in vivoBiochem Biophys Res Commun2011410353754221683689
   PubMedGoogle Scholar
• NahrendorfMKeliherEMarinelliBDetection of macrophages in aortic aneurysms by nanoparticle positron emission tomography-computed tomographyArterioscler Thromb Vasc Biol201131475075721252070
   PubMedGoogle Scholar
• LiuYWelchMJNanoparticles labeled with positron emitting nuclides: advantages, methods, and applicationsBioconjug Chem201223467168222242601
   PubMed Web of Science ®Google Scholar
• GrossmanHLMyersWRVreelandVJDetection of bacteria in suspension by using a superconducting quantum interference deviceProc Natl Acad Sci U S A2004101112913414688406
   PubMedGoogle Scholar
• FlynnERBryantHCA biomagnetic system for in vivo cancer imagingPhys Med Biol20055061273129315798322
   PubMedGoogle Scholar
• TsengWKChiehJJYangYFA noninvasive method to determine the fate of Fe3O4 nanoparticles following intravenous injection using scanning SQUID biosusceptometryPLoS One2012711e4851023152779
   PubMedGoogle Scholar
• DuynJMR Susceptibility ImagingJ Magn Reson201322919820723273840
   PubMedGoogle Scholar
• HeNLingHDingBRegion-specific disturbed iron distribution in early idiopathic Parkinson’s disease measured by quantitative susceptibility mappingHum Brain Mapp Epub20158710.1002/hbm.22928
   Google Scholar
• GunnJKParanjiRKZhangMASimple and highly sensitive method for magnetic nanoparticle quantitation using 1H-NMR spectroscopyBiophys J20099792640264719883608
   PubMedGoogle Scholar
• DahnkeHSchaeffterTLimits of detection of SPIO at 3.0 T using T2* relaxometryMagn Reson Med20055351202120615844156
   PubMed Web of Science ®Google Scholar
• BrissetJCDesestretVMarcellinoSQuantitative effects of cell internalization of two types of ultrasmall superparamagnetic iron oxide nanoparticles at 4.7 T and 7 TEur Radiol201020227528519705124
   PubMedGoogle Scholar
• PolitiLSBacigaluppiMBrambillaEMagnetic-resonance-based tracking and quantification of intravenously injected neural stem cell accumulation in the brains of mice with experimental multiple sclerosisStem Cells200725102583259217600110
   PubMed Web of Science ®Google Scholar
• LiuWFrankJADetection and quantification of magnetically labeled cells by cellular MRIEur J Radiol200970225826418995978
   PubMed Web of Science ®Google Scholar
• RadAMArbabASIskanderASJiangQSoltanian-ZadehHQuantification of superparamagnetic iron oxide (SPIO)-labeled cells using MRIJ Magn Reson Imaging200726236637417623892
   PubMed Web of Science ®Google Scholar
• LiuWDahnkeHRahmerJJordanEKFrankJAUltrashort T2* relaxometry for quantitation of highly concentrated superparamagnetic iron oxide (SPIO) nanoparticle labeled cellsMagn Reson Med200961476176619191285
   PubMed Web of Science ®Google Scholar
• GirardOMRamirezRMcCartySMattreyRFToward absolute quantification of iron oxide nanoparticles as well as cell internalized fraction using multiparametric MRIContrast Media Mol Imaging20127441141722649047
   PubMedGoogle Scholar
• FoltzWDCunninghamCHMutsaersAJConollySMStewartDJDickAJPositive-contrast imaging in the rabbit hind-limb of transplanted cells bearing endocytosed superparamagnetic beadsJ Cardiovasc Magn Reson20068681782317060104
   PubMed Web of Science ®Google Scholar
• GiladAAWalczakPMcMahonMTMR tracking of transplanted cells with “positive contrast” using manganese oxide nanoparticlesMagn Reson Med20086011718581402
   PubMed Web of Science ®Google Scholar
• KorosoglouGWeissRGKedziorekDANoninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using “positive contrast” magnetic resonance imagingJ Am Coll Cardiol200852648349118672170
   PubMedGoogle Scholar
• ManiVAdlerEBriley-SaeboKCSerial in vivo positive contrast MRI of iron oxide-labeled embryonic stem cell-derived cardiac precursor cells in a mouse model of myocardial infarctionMagn Reson Med2008601738118581415
   PubMedGoogle Scholar
• SuzukiYCunninghamCHNoguchiKIn vivo serial evaluation of superparamagnetic iron-oxide labeled stem cells by off-resonance positive contrastMagn Reson Med20086061269127519030159
   PubMedGoogle Scholar
• TaylorRMSevernsVBrownDCBisoffiMSillerudLOProstate cancer targeting motifs: expression of α(ν) β(3), neurotensin receptor 1, prostate specific membrane antigen, and prostate stem cell antigen in human prostate cancer cell lines and xenograftsProstate201272552353221748756
   PubMed Web of Science ®Google Scholar
• SerdaREAdolphiNLBisoffiMSillerudLOTargeting and cellular trafficking of magnetic nanoparticles for prostate cancer imagingMol Imaging20076427728817711783
   PubMed Web of Science ®Google Scholar
• SilverDAPellicerIFairWRHestonWDCordon-CardoCProstate-specific membrane antigen expression in normal and malignant human tissuesClin Cancer Res1997381859815541
   PubMed Web of Science ®Google Scholar
• RossJSSheehanCEFisherHACorrelation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancerClin Cancer Res20039176357636214695135
   PubMedGoogle Scholar
• TroyerJKBeckettMLWrightGLJrLocation of prostate-specific membrane antigen in the LNCaP prostate carcinoma cell lineProstate19973042322429111600
   PubMed Web of Science ®Google Scholar
• ThalmannGNAnezinisPEChangSMAndrogen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancerCancer Res199454257725818168083
   PubMed Web of Science ®Google Scholar
• BevingtonPRData Reduction and Error Analysis for the Physical SciencesNew YorkMcGraw-Hill19695665
   Google Scholar
• SlichterCPPrinciples of Magnetic ResonanceBerlinSpringer-Verlag1990
   Google Scholar
• TaylorRMHuberDLMonsonTCAliAMBisoffiMSillerudLOMultifunctional iron platinum stealth immunomicelles: Targeted detection of human prostate cancer cells using both fluorescence and magnetic resonance imagingJ Nanopart Res201113104717472922121333
   PubMed Web of Science ®Google Scholar
• KlineEETreatEGAvernaTADavisMSSmithAYSillerudLOCitrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detectionJ Urol200617652274227917070311
   PubMed Web of Science ®Google Scholar
• AvernaTAKlineEESmithAYSillerudLOA decrease in 1H NMR spectroscopically-determined citrate in human seminal fluid accompanies the development of prostate adenocarcinomaJ Urol2005173243438
   Google Scholar
• SillerudLOHallidayKRGriffeyRHFenoglio-PreiserCSheppardSIn vivo 13C NMR Spectroscopy of the Human ProstateMagn Reson Med1988822242302463457
   PubMedGoogle Scholar
• HallidayKRFenoglio-PreiserCSillerudLODifferentiation of tumor from non-malignant human tissue by natural-abundance 13C NMR in vitroAnn NY Acad Sci1987508469471
   Google Scholar
• GhoshAHestonWDTumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancerJ Cell Biochem200491352853914755683
   PubMed Web of Science ®Google Scholar
• Smith-JonesPMVallabhajosulaSNavarroVBastidasDGoldsmithSJBanderNHRadiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumorJ Nucl Med20034461061712679407
   PubMed Web of Science ®Google Scholar
• BanderNHMilowskyMINanusDMKostakogluLVallabhajosulaSGoldsmithSJPhase I trial of 177Lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancerJ Clin Oncol200523214591460115837970
   PubMed Web of Science ®Google Scholar
• MilowskyMINanusDMKostakogluLVallabhajosulaSGoldsmithSJBanderNHPhase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancerJ Clin Oncol200422132522253115173215
   PubMed Web of Science ®Google Scholar
• NanusDMMilowskyMIKostakogluLClinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigenJ Urol20031706 Pt 2S84S8814610416
   PubMed Web of Science ®Google Scholar
• BanderNHTrabulsiEJKostakogluLTargeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigenJ Urol200317051717172114532761
   PubMed Web of Science ®Google Scholar
• DenmeadeSRSokollLJDalrympleSDissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer modelsProstate200354424925712539223
   PubMedGoogle Scholar
• MurphyGPKennyGMRagdeHMeasurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancerUrology1998515A Suppl89979610563
   PubMedGoogle Scholar
• WangZCuschieriATumour cell labelling by magnetic nanoparticles with determination of intracellular iron content and spatial distribution of the intracellular ironInt J Mol Sci20131459111912523624604
   PubMedGoogle Scholar
• BarbosaJHSantosACTumasVQuantifying brain iron deposition in patients with Parkinson’s disease using quantitative susceptibility mapping, R2 and R2*Magn Reson Imaging201533555956525721997
   PubMedGoogle Scholar
• RadmardARPoustchiHDadgostarMLiver enzyme levels and hepatic iron content in fatty liver: a noninvasive assessment in general population by T2* mappingAcad Radiol201522671472125754799
   PubMedGoogle Scholar
• HaackeEMLiuSBuchSZhengWWuDYeYQuantitative susceptibility mapping: current status and future directionsMagn Reson Imaging201533112525267705
   PubMed Web of Science ®Google Scholar
• ZhangJChamberlainREtheridgeMQuantifying iron-oxide nanoparticles at high concentration based on longitudinal relaxation using a 3D SWIFT Look-Locker sequenceMagn Reson Med20147161982198824664527
   PubMed Web of Science ®Google Scholar
• NuLTargeted therapies in brain metastasesCurr Treat Options Neurol201416127624353011
   PubMedGoogle Scholar
• NeuweltASidhuNHuCAMladyGEberhardtSCSillerudLOIron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammationAm J Roentgenol20152043W302W31325714316
   PubMed Web of Science ®Google Scholar
• GagliaJLHarisinghaniMAganjINoninvasive mapping of pancreatic inflammation in recent-onset type-1 diabetes patientsProc Natl Acad Sci U S A201511272139214425650428
   PubMedGoogle Scholar